ClinicalTrials.Veeva

Menu

TARGET-Metabolic Effects (TARGET-ME)

A

Australian and New Zealand Intensive Care Research Centre

Status

Completed

Conditions

Enteral Nutrition
Critical Illness

Treatments

Dietary Supplement: TARGET protocol EN 1.5 kcal/mL

Study type

Observational

Funder types

Other

Identifiers

NCT03793244
MC_001 V1 240217

Details and patient eligibility

About

The estimation of calorie needs during routine practice in critically ill patients is highly variable and the thermogenic effect of continuous delivery of enteral nutrition (EN) on overall calorie utilisation in critically ill adults is unknown. The TARGET-ME study is a substudy of the TARGET trial (NCT02306746). The TARGET trial provides the perfect opportunity to measure calorie utilisation via indirect calorimetry (IC) and ventilator-derived carbon dioxide production (VCO2) to compare measured calorie utilisation to estimation methods, determine the potential thermic effect of EN solutions with different energy concentrations and investigate any associations with outcome.

Enrollment

42 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients must first meet the inclusion and none of the exclusion criteria for the TARGET main trail (NCT02306746). The following additional criteria applies for this study when indirect calorimetry is being used:

  • Within 48 hours of randomisation to TARGET (first measurement only)
  • Fi02 < 50% for the past 1 hour
  • Positive end expiratory pressure (PEEP) < 12 mmHg for the past 1 hour
  • The IC test can be conducted within 48 hours of randomisation to TARGET
  • The patient is not considered agitated using the usual site assessment
  • There is a clinician available to complete the test

Exclusion criteria

  • There is an air leak in the ventilation circuit (ie bubbling inter-costal catheters, cuff leak at the endotracheal tube
  • The patient is receiving renal replacement therapy or extracorporeal membrane oxygenation at the time of measurement
  • Has had surgery in the last 6 hours (if enough time within the 48 hour window, consider waiting until this criteria is less than 6 hours)
  • If the patient has a traumatic brain injury, for the previous 6 hours, their intracranial pressures have been unstable and in the opinion of the treating intensivist are not controlled
  • The treating clinician believes that the IC test will pose risk to the patient

Trial design

42 participants in 2 patient groups

Experimental: TARGET protocol EN 1.5 kcal/mL
Description:
Enteral (EN) feed 1.5 kcal/mL. Indirect calorimetry and/or VCO2 measurements will be taken periodically while in the TARGET main study
Treatment:
Dietary Supplement: TARGET protocol EN 1.5 kcal/mL
Active Comparator: TARGET protocol EN 1.0 kcal/mL
Description:
Enteral feed 1.0 kcal/mL Indirect calorimetry and/or VCO2 measurements will be taken periodically while in the TARGET main study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems